Use of proton pump inhibitors in adults in France: a nationwide drug utilization study

Marion Lassalle(Conservatoire National des Arts et Métiers), Rosemary Dray‐Spira(Agence Nationale de Sécurité du Médicament et des Produits de Santé), Mahmoud Zureik(Inserm), Marc Bardou(CHU Dijon Bourgogne), Nathalie Dumarcet(Agence Nationale de Sécurité du Médicament et des Produits de Santé), Julien Kirchgesner(Université Paris-Est Créteil), M Biour(Assistance Publique – Hôpitaux de Paris), Thien Le Tri(Conservatoire National des Arts et Métiers), Frank Rouby(Inserm)
European Journal of Clinical Pharmacology
December 14, 2019
10.1007/s00228-019-02810-1
Cited by 130

Related Papers

Rhinitis and onset of asthma: a longitudinal population-based study
|The Lancet|2008|613
Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease
|JAMA|2017|550
Gender differences in prevalence, diagnosis and incidence of allergic and non-allergic asthma: a population-based cohort
|Thorax|2012|265
Proton Pump Inhibitor Use and Risk of Serious Infections in Young Children
|JAMA Pediatrics|2023|77
Working conditions and psychotropic drug use: Cross-sectional and prospective results from the French national SIP study
|Journal of Psychiatric Research|2015|34